{
  "id" : "5d9d45b4-567a-4670-8582-5643f185855c",
  "resourceType" : "StructureDefinition",
  "url" : "https://datatools4heart.eu/fhir/schemas/NHFA/NHFA-v5",
  "name" : "NHFA-v5",
  "status" : "draft",
  "fhirVersion" : "5.0.0",
  "kind" : "logical",
  "abstract" : false,
  "type" : "NHFA-v5",
  "baseDefinition" : "http://hl7.org/fhir/StructureDefinition/Element",
  "derivation" : "specialization",
  "differential" : {
    "element" : [ {
      "id" : "NHFA-v5",
      "path" : "NHFA-v5",
      "min" : 0,
      "max" : "*",
      "type" : [ {
        "code" : "Element"
      } ]
    }, {
      "id" : "NHFA-v5.hospital_identifier",
      "path" : "NHFA-v5.hospital_identifier",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "This will be automatically populated based on the account with which you log into the database.",
      "short" : "hospital_identifier"
    }, {
      "id" : "NHFA-v5.local_patient_identifier",
      "path" : "NHFA-v5.local_patient_identifier",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The patient's hospital number or unique local identifier.",
      "short" : "local_patient_identifier"
    }, {
      "id" : "NHFA-v5.nhs_number",
      "path" : "NHFA-v5.nhs_number",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The patient's unique 10 digit NHS number with no spaces.",
      "short" : "nhs_number"
    }, {
      "id" : "NHFA-v5.patient_surname",
      "path" : "NHFA-v5.patient_surname",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The patient's surname, as used on official documentation.",
      "short" : "patient_surname"
    }, {
      "id" : "NHFA-v5.patient_name",
      "path" : "NHFA-v5.patient_name",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The patient's forename, as used on official documentation. Including additional forenames is optional.",
      "short" : "patient_name"
    }, {
      "id" : "NHFA-v5.date_of_birth",
      "path" : "NHFA-v5.date_of_birth",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "date",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/date" ]
      } ],
      "definition" : "This must be a valid date, in the format dd/mm/yyyy. Patients must be 18 years old and over to be entered into the database.",
      "short" : "date_of_birth"
    }, {
      "id" : "NHFA-v5.patient_sex",
      "path" : "NHFA-v5.patient_sex",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The sex of the patient at birth.",
      "short" : "patient_sex"
    }, {
      "id" : "NHFA-v5.ethnic_category",
      "path" : "NHFA-v5.ethnic_category",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The self-determined ethnicity of the patient.",
      "short" : "ethnic_category"
    }, {
      "id" : "NHFA-v5.postcode",
      "path" : "NHFA-v5.postcode",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The postcode of address nominated by the patient as their main permanent residence. Use pseudo postcodes for visitors.",
      "short" : "postcode"
    }, {
      "id" : "NHFA-v5.gp_name",
      "path" : "NHFA-v5.gp_name",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "short" : "gp_name"
    }, {
      "id" : "NHFA-v5.date_of_admission",
      "path" : "NHFA-v5.date_of_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "date",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/date" ]
      } ],
      "definition" : "Date of admission to hospital. If date of admission to hospital and date of admission to ward are different (e.g. the patient was admitted to A &E before midnight, but moved to a ward after midnight) the earlier date should be used.",
      "short" : "date_of_admission"
    }, {
      "id" : "NHFA-v5.Is_this_an_emergency_admission_for_heart_failure",
      "path" : "NHFA-v5.Is_this_an_emergency_admission_for_heart_failure",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "You can either respond 'yes' to questions about either emergency or elective admission but not both. Emergency admission refers to an 'Unplanned or 'Non Elective' admissions. Elective admission refers to a patient admitted for elective surgery.",
      "short" : "Is_this_an_emergency_admission_for_heart_failure"
    }, {
      "id" : "NHFA-v5.Is_this_a_elective_admission",
      "path" : "NHFA-v5.Is_this_a_elective_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "You can either respond 'yes' to questions about either emergency or elective admission but not both. Emergency admission refers to an 'Unplanned or 'Non Elective' admissions. Elective admission refers to a patient admitted for elective surgery.",
      "short" : "Is_this_a_elective_admission"
    }, {
      "id" : "NHFA-v5.main_place_of_care",
      "path" : "NHFA-v5.main_place_of_care",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ward in which the patient received the majority of their care. If the patient was treated for an equal amount of time on two wards, the latter ward of treatment should be recorded. Ambulatory care/ Diuretic Lounge refers to patients who require admission to hospital but local practice has allowed care to be in an ambulatory setting (this is not recommended practice but it allows for submissions to count towards HES).  ",
      "short" : "main_place_of_care"
    }, {
      "id" : "NHFA-v5.specialist_input",
      "path" : "NHFA-v5.specialist_input",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "The heart failure specialist clinicians that had input into the patient's care. Multiple values can be selected, but unknown cannot be selected in combination with other values.",
      "short" : "specialist_input"
    }, {
      "id" : "NHFA-v5.breathlessness",
      "path" : "NHFA-v5.breathlessness",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "This is a standard breathlessness score used to assign New York Heart Association Classification on admission.\n1=NYHA Class I: ordinary physical activity does not cause fatigue, breathlessness or palpitation\n2=NYHA Class II: patients are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, breathlessness or angina pectoris \n3=NYHA Class III: although patients are comfortable at rest, less than ordinary activity will lead to symptoms\n4=NYHA Class IV: symptoms of congestive cardiac failure are present even at rest. Increased discomfort with any physical activity.",
      "short" : "breathlessness"
    }, {
      "id" : "NHFA-v5.peripheral_oedema",
      "path" : "NHFA-v5.peripheral_oedema",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Ankle or sacral oedema on admission\n1=pitting oedema to the ankle\n2=oedema between ankle and knee\n3=oedema above the knee",
      "short" : "peripheral_oedema"
    }, {
      "id" : "NHFA-v5.ihd",
      "path" : "NHFA-v5.ihd",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "History of Myocardial Infarction (MI), Angina, ECG evidence of MI, CABG or Angiogram documenting Coronary Artery Disease.",
      "short" : "ihd"
    }, {
      "id" : "NHFA-v5.device_therapy",
      "path" : "NHFA-v5.device_therapy",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Device therapy either during this admission or at a previous time. If multiple devices have been implanted, the current device should be recorded. If the patient previously had a device, and this has been removed, '0. None' should be selected.\n\n0=None\n1=Cardiac Resynchronisation Therapy (CRT) defibrillator\n2=CRT pacemaker\n3=Implantable Cardioverter Defibrillator\n4=Pacemaker\n5=No indication for device\n9=Unknown\n12=Declined by patient\n",
      "short" : "device_therapy"
    }, {
      "id" : "NHFA-v5.device_mode",
      "path" : "NHFA-v5.device_mode",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Device mode for devices fitted either during or prior to this admission. If multiple devices/modes have been used, the current device should be recorded.",
      "short" : "device_mode"
    }, {
      "id" : "NHFA-v5.valve_disease",
      "path" : "NHFA-v5.valve_disease",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "History of clinically diagnosed valve disease, moderate or severe stenosis or regurgitation on imaging, or an operative valve replacement/repair",
      "short" : "valve_disease"
    }, {
      "id" : "NHFA-v5.congenital_heart_disease",
      "path" : "NHFA-v5.congenital_heart_disease",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "A defect of the heart or great vessels that has been present since birth.",
      "short" : "congenital_heart_disease"
    }, {
      "id" : "NHFA-v5.hypertension",
      "path" : "NHFA-v5.hypertension",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Recorded  BP >140/90 on at least two occasions prior to admission, or already receiving treatment (drug, dietary or lifestyle) for hypertension.",
      "short" : "hypertension"
    }, {
      "id" : "NHFA-v5.atrial_fibrillation_flutter",
      "path" : "NHFA-v5.atrial_fibrillation_flutter",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "1. Yes - On admission (An ECG was performed showing atrial fibrillation/flutter). Paroxysmal Atrial fibrillation (PAF): if the patient is in sinus rhythm but is known to have PAF please select option 1.\n2. Never\n9. Unknown",
      "short" : "atrial_fibrillation_flutter"
    }, {
      "id" : "NHFA-v5.diabetes",
      "path" : "NHFA-v5.diabetes",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Diagnosis of diabetes prior to admission. This includes a confirmed diagnosis of diabetes and/or the use of an oral hypoglycaemic agent or insulin, and/or a fasting blood glucose >6.7, and/or a random blood glucose >11.",
      "short" : "diabetes"
    }, {
      "id" : "NHFA-v5.asthma",
      "path" : "NHFA-v5.asthma",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "History of childhood asthma and atopy, or asthma confirmed by a respiratory physician for adult onset.",
      "short" : "asthma"
    }, {
      "id" : "NHFA-v5.cerebral_vascular_accident",
      "path" : "NHFA-v5.cerebral_vascular_accident",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "A past neurological deficit of cerebrovascular cause, including episodes that persist beyond 24 hours and transient ischaemic attacks lasting less than 24 hours.",
      "short" : "cerebral_vascular_accident"
    }, {
      "id" : "NHFA-v5.chronic_obstructive_pulmonary_disease",
      "path" : "NHFA-v5.chronic_obstructive_pulmonary_disease",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "History of COPD - chronic bronchitis, emphysema or their co-occurrence. Must be indicated by pulmonary function testing evidence. I.e. FEV1<75% predicted value or use of beta agonist/steroid inhalers.",
      "short" : "chronic_obstructive_pulmonary_disease"
    }, {
      "id" : "NHFA-v5.cardiomyopathy",
      "path" : "NHFA-v5.cardiomyopathy",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "cardiomyopathy"
    }, {
      "id" : "NHFA-v5.smoking_history",
      "path" : "NHFA-v5.smoking_history",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Patient's history of smoking.",
      "short" : "smoking_history"
    }, {
      "id" : "NHFA-v5.previous_malignancy",
      "path" : "NHFA-v5.previous_malignancy",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "previous_malignancy"
    }, {
      "id" : "NHFA-v5.current_malignancy",
      "path" : "NHFA-v5.current_malignancy",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "current_malignancy"
    }, {
      "id" : "NHFA-v5.amyloid",
      "path" : "NHFA-v5.amyloid",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "amyloid"
    }, {
      "id" : "NHFA-v5.ace_inhibitor",
      "path" : "NHFA-v5.ace_inhibitor",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ACE inhibitor that the patient was prescribed at point of admission to hospital (i.e. prescribed before admission). Contraindicated should be selected if an ACE inhibitor is not tolerated by the patient, e.g. if it causes a severe cough, Symptomatic hypotension  or renal dysfunction. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has.",
      "short" : "ace_inhibitor"
    }, {
      "id" : "NHFA-v5.ace_inhibitor_dose",
      "path" : "NHFA-v5.ace_inhibitor_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ACE inhibitor dose on admission - do not include dose if ACE inhibitor is recorded as 'Other'",
      "short" : "ace_inhibitor_dose"
    }, {
      "id" : "NHFA-v5.ace_i_contraindication",
      "path" : "NHFA-v5.ace_i_contraindication",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "\"The wording was changed from cough to Cough (severe). Term Low arterial  pressure changed to Symptomatic hypotension. If ACE inhibitor was contraindicated on admission, the reason given.\n1=The cause of cough sever should be investigated and ACEI stopped only when cough is very troublesome, persistent and not due to other causes.\n2=A low pressure that is asymptomatic and is not comprising renal function or other end-organs is not a reason to stop an ACEI.\n3=Serum creatinine exceeding 250umol/L.\n4=Other intolerance to ACE\n6=Serum potassium >5.5mmol/L.\"\n7. Angioedema\"\n",
      "short" : "ace_i_contraindication"
    }, {
      "id" : "NHFA-v5.arb",
      "path" : "NHFA-v5.arb",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ARB that the patient was prescribed at point of admission to hospital. Contraindicated should be selected if an ARB is not tolerated by the patient. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has.                                                                                                                                                                                                   If the person is on ARNI, tick ARNI and not ARB.",
      "short" : "arb"
    }, {
      "id" : "NHFA-v5.arb_dose",
      "path" : "NHFA-v5.arb_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ARB dose on admission - do not include dose if ARB is recorded as 'other'",
      "short" : "arb_dose"
    }, {
      "id" : "NHFA-v5.beta_blocker",
      "path" : "NHFA-v5.beta_blocker",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The beta blocker that the patient was prescribed at point of admission to hospital. Contraindicated should be selected if a beta blocker is not tolerated by the patient, e.g. if it causes bradycardia or heart block, low arterial pressure, worsening heart failure, intolerable fatigue or respiratory disease. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has.",
      "short" : "beta_blocker"
    }, {
      "id" : "NHFA-v5.beta_blocker_dose",
      "path" : "NHFA-v5.beta_blocker_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Beta blocker dose on admission - do not include dose if beta blocker is recorded as 'Other'",
      "short" : "beta_blocker_dose"
    }, {
      "id" : "NHFA-v5.beta_blocker_contraindication",
      "path" : "NHFA-v5.beta_blocker_contraindication",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "If beta blocker was contraindicated on admission, state the reason given.\n9=Beta Blockers are only contraindicated if there is significant asthma. This is defined as history of childhood asthma and atopy, or confirmed by respiratory physician for adult onset.",
      "short" : "beta_blocker_contraindication"
    }, {
      "id" : "NHFA-v5.loop_diuretic",
      "path" : "NHFA-v5.loop_diuretic",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The loop diuretic that the patient was prescribed at point of admission to hospital. Contraindicated should be selected if a loop diuretic is not tolerated by the patient. Not indicated should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has.",
      "short" : "loop_diuretic"
    }, {
      "id" : "NHFA-v5.loop_diuretic_dose",
      "path" : "NHFA-v5.loop_diuretic_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Loop diuretic dose on admission - do not include dose if loop diuretic is recorded as 'other'",
      "short" : "loop_diuretic_dose"
    }, {
      "id" : "NHFA-v5.thiazide_or_metolazone",
      "path" : "NHFA-v5.thiazide_or_metolazone",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Thiazide or metolazone prescribed at point of admission to hospital. Contraindicated should be selected if thiazide or metolazone is not tolerated by the patient. Not indicated should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Other Thiazide/Metolazone refers to any other diuretic on admission. ",
      "short" : "thiazide_or_metolazone"
    }, {
      "id" : "NHFA-v5.thiazide_dose",
      "path" : "NHFA-v5.thiazide_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Thiazide or metolazone dose on admission - do not include dose if thiazide/Metolazone is recorded as 'other'",
      "short" : "thiazide_dose"
    }, {
      "id" : "NHFA-v5.mra",
      "path" : "NHFA-v5.mra",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The MRA that the patient was prescribed at point of admission to hospital. Contraindicated should be selected if an MRA is not tolerated by the patient, e.g. if it causes hyperkalaemia, renal dysfunction or gynaecomastia. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has.",
      "short" : "mra"
    }, {
      "id" : "NHFA-v5.mra_contraindication",
      "path" : "NHFA-v5.mra_contraindication",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "If MRA was contraindicated on admission, state the reason given.",
      "short" : "mra_contraindication"
    }, {
      "id" : "NHFA-v5.mra_dose",
      "path" : "NHFA-v5.mra_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "MRA dose on admission - do not include dose if MRA is recorded as 'other'",
      "short" : "mra_dose"
    }, {
      "id" : "NHFA-v5.aspirin",
      "path" : "NHFA-v5.aspirin",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Aspirin prescribed at point of admission to hospital.",
      "short" : "aspirin"
    }, {
      "id" : "NHFA-v5.aspirin_dose",
      "path" : "NHFA-v5.aspirin_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Aspirin dose on admission",
      "short" : "aspirin_dose"
    }, {
      "id" : "NHFA-v5.other_oral_anti_platelet",
      "path" : "NHFA-v5.other_oral_anti_platelet",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Any oral antiplatelet, other than aspirin, prescribed at point of admission to hospital",
      "short" : "other_oral_anti_platelet"
    }, {
      "id" : "NHFA-v5.digoxin",
      "path" : "NHFA-v5.digoxin",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Digoxin prescribed at point of admission to hospital",
      "short" : "digoxin"
    }, {
      "id" : "NHFA-v5.digoxin_dose",
      "path" : "NHFA-v5.digoxin_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Digoxin dose on admission",
      "short" : "digoxin_dose"
    }, {
      "id" : "NHFA-v5.ccb",
      "path" : "NHFA-v5.ccb",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The calcium channel blocker that the patient was prescribed at point of admission to hospital",
      "short" : "ccb"
    }, {
      "id" : "NHFA-v5.ccb_dose",
      "path" : "NHFA-v5.ccb_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Calcium channel blocker dose on admission",
      "short" : "ccb_dose"
    }, {
      "id" : "NHFA-v5.statin",
      "path" : "NHFA-v5.statin",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Statin prescribed at point of admission to hospital",
      "short" : "statin"
    }, {
      "id" : "NHFA-v5.statin_dose",
      "path" : "NHFA-v5.statin_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Statin dose on admission",
      "short" : "statin_dose"
    }, {
      "id" : "NHFA-v5.warfarin",
      "path" : "NHFA-v5.warfarin",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Warfarin prescribed at point of admission to hospital",
      "short" : "warfarin"
    }, {
      "id" : "NHFA-v5.inr",
      "path" : "NHFA-v5.inr",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "INR on admission",
      "short" : "inr"
    }, {
      "id" : "NHFA-v5.other_oral_anticoagulant",
      "path" : "NHFA-v5.other_oral_anticoagulant",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Any oral anticoagulant, other than warfarin, prescribed at point of admission to hospital",
      "short" : "other_oral_anticoagulant"
    }, {
      "id" : "NHFA-v5.other_oral_anticoagulant_dose",
      "path" : "NHFA-v5.other_oral_anticoagulant_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Oral anticoagulant dose on admission",
      "short" : "other_oral_anticoagulant_dose"
    }, {
      "id" : "NHFA-v5.amiodarone",
      "path" : "NHFA-v5.amiodarone",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Amiodarone prescribed at point of admission to hospital",
      "short" : "amiodarone"
    }, {
      "id" : "NHFA-v5.amiodarone_dose",
      "path" : "NHFA-v5.amiodarone_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Amiodarone dose on admission",
      "short" : "amiodarone_dose"
    }, {
      "id" : "NHFA-v5.allopurinol",
      "path" : "NHFA-v5.allopurinol",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Allopurinol prescribed at point of admission to hospital",
      "short" : "allopurinol"
    }, {
      "id" : "NHFA-v5.allopurinol_dose",
      "path" : "NHFA-v5.allopurinol_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Allopurinol dose on admission",
      "short" : "allopurinol_dose"
    }, {
      "id" : "NHFA-v5.nsaid",
      "path" : "NHFA-v5.nsaid",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Non-steroidal anti-inflammatory drug prescribed at point of admission to hospital",
      "short" : "nsaid"
    }, {
      "id" : "NHFA-v5.oral_nitrates",
      "path" : "NHFA-v5.oral_nitrates",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Oral nitrates prescribed at point of admission to hospital",
      "short" : "oral_nitrates"
    }, {
      "id" : "NHFA-v5.oral_nitrates_dose",
      "path" : "NHFA-v5.oral_nitrates_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Oral nitrates dose on admission",
      "short" : "oral_nitrates_dose"
    }, {
      "id" : "NHFA-v5.bronchodilators",
      "path" : "NHFA-v5.bronchodilators",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Bronchodilators prescribed at point of admission to hospital",
      "short" : "bronchodilators"
    }, {
      "id" : "NHFA-v5.diabetes_therapy",
      "path" : "NHFA-v5.diabetes_therapy",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "'The diabetes therapy that the patient was prescribed at point of admission. Drug therapy stopped should be selected if the patient was taking a diabetes therapy when admitted, and it was stopped during the admission. Diabetes therapy 0. No to be selected on its own (no other options can be selected if 0. No is chosen). Please complete the SGLT2 inhibitors field if this option is selected.",
      "short" : "diabetes_therapy"
    }, {
      "id" : "NHFA-v5.ivabradine",
      "path" : "NHFA-v5.ivabradine",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Ivabradine prescribed at point of admission to hospital",
      "short" : "ivabradine"
    }, {
      "id" : "NHFA-v5.ivabradine_dose",
      "path" : "NHFA-v5.ivabradine_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Ivabradine dose on admission",
      "short" : "ivabradine_dose"
    }, {
      "id" : "NHFA-v5.hydralazine",
      "path" : "NHFA-v5.hydralazine",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Hydralazine prescribed at point of admission to hospital",
      "short" : "hydralazine"
    }, {
      "id" : "NHFA-v5.hydralazine_dose",
      "path" : "NHFA-v5.hydralazine_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Hydralazine dose on admission",
      "short" : "hydralazine_dose"
    }, {
      "id" : "NHFA-v5.arni",
      "path" : "NHFA-v5.arni",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "ARNI (Admission)",
      "short" : "arni"
    }, {
      "id" : "NHFA-v5.arni_dose",
      "path" : "NHFA-v5.arni_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ARNI dose at on admission, 50mg to 400mg  - do not include dose if ARNI is recorded as 'Other ARNI'",
      "short" : "arni_dose"
    }, {
      "id" : "NHFA-v5.arni_contraindication",
      "path" : "NHFA-v5.arni_contraindication",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "arni_contraindication"
    }, {
      "id" : "NHFA-v5.height",
      "path" : "NHFA-v5.height",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Height in cm - any recorded adult height that can be found in the notes. If unknown, record as 0. If not measured, record as -1.",
      "short" : "height"
    }, {
      "id" : "NHFA-v5.weight_discharge",
      "path" : "NHFA-v5.weight_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Weight in kilograms, measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "weight_discharge"
    }, {
      "id" : "NHFA-v5.weight_admission",
      "path" : "NHFA-v5.weight_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Weight in kilograms, measured on admission or first available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "weight_admission"
    }, {
      "id" : "NHFA-v5.heart_rate_discharge",
      "path" : "NHFA-v5.heart_rate_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Heart rate in beats per minute (bpm), measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "heart_rate_discharge"
    }, {
      "id" : "NHFA-v5.heart_rate_admission",
      "path" : "NHFA-v5.heart_rate_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Heart rate in beats per minute (bpm), measured on admission or first available recording after admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "heart_rate_admission"
    }, {
      "id" : "NHFA-v5.systolic_blood_pressure_discharge",
      "path" : "NHFA-v5.systolic_blood_pressure_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Systolic blood pressure of patient in mmHG, measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "systolic_blood_pressure_discharge"
    }, {
      "id" : "NHFA-v5.systolic_blood_pressure_admission",
      "path" : "NHFA-v5.systolic_blood_pressure_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Systolic blood pressure of patient in mmHG, measured on admission or first available recording after admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "systolic_blood_pressure_admission"
    }, {
      "id" : "NHFA-v5.hb_discharge",
      "path" : "NHFA-v5.hb_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Haemoglobin level in grams per litre (g/L). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "hb_discharge"
    }, {
      "id" : "NHFA-v5.urea_discharge",
      "path" : "NHFA-v5.urea_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "The units have changed from milligrams per decilitre (mg/dL) to millimoles per litre (mmol/L). Urea level in millimoles per litre (mmol/L: min and max range 1-99). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "urea_discharge"
    }, {
      "id" : "NHFA-v5.creatinine_discharge",
      "path" : "NHFA-v5.creatinine_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Creatinine level in micromoles per litre (μmol/L). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "creatinine_discharge"
    }, {
      "id" : "NHFA-v5.serum_sodium_discharge",
      "path" : "NHFA-v5.serum_sodium_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "The units have changed from milliequivalents per litre (mEq/L) to millimoles per litre (mmol/L). Sodium level in millimoles per litre (mmol/L min and max range 110-150). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "serum_sodium_discharge"
    }, {
      "id" : "NHFA-v5.serum_potassium_discharge",
      "path" : "NHFA-v5.serum_potassium_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "The units have changed from milliequivalents per litre (mEq/L) to millimoles per litre (mmol/L). Potassium level in millimoles per litre (mmol/L min and max range 1-8 ). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "serum_potassium_discharge"
    }, {
      "id" : "NHFA-v5.creatinine_admission",
      "path" : "NHFA-v5.creatinine_admission",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Creatinine level in micromoles per litre (μmol/L ). Measured on admission or first available recording after admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "creatinine_admission"
    }, {
      "id" : "NHFA-v5.bnp",
      "path" : "NHFA-v5.bnp",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "A record of the patient's B-type Natriuretic Peptide (BNP) level in picograms per millilitre (pg/mL). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "bnp"
    }, {
      "id" : "NHFA-v5.nt_pro_bnp",
      "path" : "NHFA-v5.nt_pro_bnp",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "A record of the patient's N-terminal prohormone of BNP (NT-proBNP) level in picograms per millilitre (pg/mL). Measured on discharge or last available recording during admission. If unknown, record as 0  - this will be counted as an incomplete field. If not measured, record as -1.",
      "short" : "nt_pro_bnp"
    }, {
      "id" : "NHFA-v5.qrs_duration",
      "path" : "NHFA-v5.qrs_duration",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "The QRS duration in millisecond (ms), if an ECG was performed. If unknown, record as 0.",
      "short" : "qrs_duration"
    }, {
      "id" : "NHFA-v5.ecg",
      "path" : "NHFA-v5.ecg",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "Results of an electrocardiogram (ECG/EKG) performed during the admission:If an ECG was performed, then please respond to the QRS field. If an ECG is unknown, record as 0.\n1=An ECG was performed, and heartbeat was normal. \n2=An ECG was performed showing atrial fibrillation/flutter.\n3=An ECG was performed showing left bundle branch block (LBBB). \n4=An ECG was performed showing a previous myocardial infarction (MI). \n5=An ECG was performed showing right bundle branch block (RBBB). \n8=An ECG was performed showing a rhythm not listed above OR an electrocardiogram was performed but information about heart rhythm is unknown. \n9=Information about ECG is not available. \n10=An ECG was not performed during this admission.\nMultiple options can be selected but note that 9 and 10 cannot be selected in combination with any other values.If an ECG was performed, then please respond to the QRS field. If an ECG is unknown, record as 0.",
      "short" : "ecg"
    }, {
      "id" : "NHFA-v5.gold_standard_test",
      "path" : "NHFA-v5.gold_standard_test",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "string",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/string" ]
      } ],
      "definition" : "Results of echocardiography, or other gold standard test (including MRI, nuclear scan, angiogram and CT scan) during this admission or in the 12 months prior to admission.\n0= An echo (or other test) was undertaken, and heart function was normal.\n1=Moderate or severe left ventricular systolic dysfunction (e.g. a left ventricular ejection fraction (LVEF) ≤40% or eyeball method of assessment).\n2=Moderate or severe left ventricular hypertrophy reported on an imaging test (e.g. LV posterior wall dimension in diastole >1.3cm and/or septal dimension >1.3cm).\n3=Moderate or severe stenosis or regurgitation on imaging, or an operative valve replacement/repair. Prosthetic valves do not need to be included here.\n4=Moderate or severe diastolic dysfunction.\n5=Enlarged left atrium                                                                                                                                                                                                     6= Cor Pulmonale/Right Heart failure due to lung disease\n8=An echo (or other test) was undertaken and some other diagnosis was given OR its outcome is unknown.\n9=Information about the performance of a gold standard test is not available.\n10=An echo (or other test) was not performed during this admission or in the previous 12 months. \n11= Mild systolic dysfunction (e.g. a left ventricular ejection fraction(LVEF 41% - 49% or eyeball method of assessment).                                                                                                                                                                       Multiple options can be selected but note that 8, 9 and 10 cannot be selected in combination with any other values.'\n                                                                                                                                                                          ",
      "short" : "gold_standard_test"
    }, {
      "id" : "NHFA-v5.lvef",
      "path" : "NHFA-v5.lvef",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Echo preferred but any other method of measurement allowed.",
      "short" : "lvef"
    }, {
      "id" : "NHFA-v5.gold_standard_test_date",
      "path" : "NHFA-v5.gold_standard_test_date",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "date",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/date" ]
      } ],
      "definition" : "If Echo options either 8,9 or 10 is selected then 'Date of most recent Echo or other gold standard test (including MRI, nuclear scan, angiogram and CT scan), from which  the LVEF was measured or estimated, recorded during this admission or in the 12 months prior to admission'",
      "short" : "gold_standard_test_date"
    }, {
      "id" : "NHFA-v5.mri_systolic_dysfunction",
      "path" : "NHFA-v5.mri_systolic_dysfunction",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Systolic dysfunction diagnosed through MRI scan.",
      "short" : "mri_systolic_dysfunction"
    }, {
      "id" : "NHFA-v5.chest_x_ray_cardiothoracic_ratio",
      "path" : "NHFA-v5.chest_x_ray_cardiothoracic_ratio",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Cardiothoracic ratio (ratio of the maximal horizontal cardiac diameter and the maximal horizontal thoracic diameter) measured using a chest x-ray.",
      "short" : "chest_x_ray_cardiothoracic_ratio"
    }, {
      "id" : "NHFA-v5.chest_x_ray_pulmonary_oedema",
      "path" : "NHFA-v5.chest_x_ray_pulmonary_oedema",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Pulmonary oedema, diagnosed using a chest x-ray.",
      "short" : "chest_x_ray_pulmonary_oedema"
    }, {
      "id" : "NHFA-v5.ace_inhibitor_discharge",
      "path" : "NHFA-v5.ace_inhibitor_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ACE inhibitor that the patient was prescribed at point of discharge. Contraindicated should be selected if an ACE inhibitor is not tolerated by the patient, e.g. if it causes a severe cough, symptomatic hypotension  or unacceptable renal dysfunction. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "ace_inhibitor_discharge"
    }, {
      "id" : "NHFA-v5.ace_inhibitor_dose_discharge",
      "path" : "NHFA-v5.ace_inhibitor_dose_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ACE inhibitor dose at discharge - do not include dose if ACE inhibitor is recorded as 'Other'",
      "short" : "ace_inhibitor_dose_discharge"
    }, {
      "id" : "NHFA-v5.ace_i_contraindication_discharge",
      "path" : "NHFA-v5.ace_i_contraindication_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "\"The wording was changed from Cough to Cough (severe). Term Low arterial  pressure changed to Symptomatic hypotension. If ACE inhibitor was contraindicated on admission, state the reason given.\n1=The cause of cough severe should be investigated and ACEI stopped only when cough is very troublesome, persistent and not due to other causes.\n2=A low pressure that is asymptomatic and is not comprising renal function or other end-organs is not a reason to stop an ACEI.\n3=Serum creatinine exceeding 250umol/L.\n4=Other intolerance to ACE\n6=Serum potassium >5.5mmol/L.\"\n7. Angioedema\"\n",
      "short" : "ace_i_contraindication_discharge"
    }, {
      "id" : "NHFA-v5.arb_discharge",
      "path" : "NHFA-v5.arb_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ARB that the patient was prescribed at point of discharge. Contraindicated should be selected if an ARB is not tolerated by the patient. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "arb_discharge"
    }, {
      "id" : "NHFA-v5.arb_discharge_dose",
      "path" : "NHFA-v5.arb_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ARB dose at discharge - do not include dose if ARB is recorded as 'Other'",
      "short" : "arb_discharge_dose"
    }, {
      "id" : "NHFA-v5.beta_blocker_discharge",
      "path" : "NHFA-v5.beta_blocker_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The beta blocker that the patient was prescribed at point of discharge. Contraindicated should be selected if a beta blocker is not tolerated by the patient, e.g. if it causes bradycardia or heart block, low arterial pressure, worsening heart failure, intolerable fatigue or respiratory disease. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "beta_blocker_discharge"
    }, {
      "id" : "NHFA-v5.beta_blocker_discharge_dose",
      "path" : "NHFA-v5.beta_blocker_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Beta blocker dose at discharge - do not include dose if beta blocker is recorded as 'Other'",
      "short" : "beta_blocker_discharge_dose"
    }, {
      "id" : "NHFA-v5.beta_blocker_contraindication_discharge",
      "path" : "NHFA-v5.beta_blocker_contraindication_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "If beta blockers were contraindicated at discharge, state the reason given.\n8=Asthma is defined as history of childhood asthma and atopy, or confirmed by respiratory physician for adult onset.",
      "short" : "beta_blocker_contraindication_discharge"
    }, {
      "id" : "NHFA-v5.loop_diuretic_discharge",
      "path" : "NHFA-v5.loop_diuretic_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The loop diuretic that the patient was prescribed at point of discharge. Contraindicated should be selected if a loop diuretic is not tolerated by the patient. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "loop_diuretic_discharge"
    }, {
      "id" : "NHFA-v5.loop_diuretic_discharge_dose",
      "path" : "NHFA-v5.loop_diuretic_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Loop diuretic dose at discharge - do not include dose if loop diuretic is recorded as 'Other'",
      "short" : "loop_diuretic_discharge_dose"
    }, {
      "id" : "NHFA-v5.thiazide_or_metolazone_discharge",
      "path" : "NHFA-v5.thiazide_or_metolazone_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Thiazide or metolazone prescribed at point of discharge. Contraindicated should be selected if thiazide or metolazone is not tolerated by the patient. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission. Other Thiazide/Metolazone refers to any other diuretic on discharge. ",
      "short" : "thiazide_or_metolazone_discharge"
    }, {
      "id" : "NHFA-v5.thiazide_or_metolazone_discharge_dose",
      "path" : "NHFA-v5.thiazide_or_metolazone_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Thiazide or metolazone dose at discharge - do not include dose if thiazide/metolazone is recorded as 'Other'",
      "short" : "thiazide_or_metolazone_discharge_dose"
    }, {
      "id" : "NHFA-v5.mra_discharge",
      "path" : "NHFA-v5.mra_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The MRA that the patient was prescribed at point of discharge. Contraindicated should be selected if an MRA is not tolerated by the patient, e.g. if it causes hyperkalaemia, renal dysfunction or gynaecomastia. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "mra_discharge"
    }, {
      "id" : "NHFA-v5.mra_contraindication_discharge",
      "path" : "NHFA-v5.mra_contraindication_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "mra_contraindication_discharge"
    }, {
      "id" : "NHFA-v5.mra_dose_discharge",
      "path" : "NHFA-v5.mra_dose_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "MRA dose at discharge - do not include dose if MRA is recorded as 'Other'",
      "short" : "mra_dose_discharge"
    }, {
      "id" : "NHFA-v5.aspirin_discharge",
      "path" : "NHFA-v5.aspirin_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Aspirin prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "aspirin_discharge"
    }, {
      "id" : "NHFA-v5.aspirin_discharge_dose",
      "path" : "NHFA-v5.aspirin_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Aspirin dose at discharge.",
      "short" : "aspirin_discharge_dose"
    }, {
      "id" : "NHFA-v5.other_oral_anti_platelet_discharge",
      "path" : "NHFA-v5.other_oral_anti_platelet_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Any oral antiplatelet, other than aspirin, prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "other_oral_anti_platelet_discharge"
    }, {
      "id" : "NHFA-v5.digoxin_discharge",
      "path" : "NHFA-v5.digoxin_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Digoxin prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "digoxin_discharge"
    }, {
      "id" : "NHFA-v5.digoxin_discharge_dose",
      "path" : "NHFA-v5.digoxin_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Digoxin dose at discharge.",
      "short" : "digoxin_discharge_dose"
    }, {
      "id" : "NHFA-v5.ccb_discharge",
      "path" : "NHFA-v5.ccb_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The calcium channel blocker that the patient was prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "ccb_discharge"
    }, {
      "id" : "NHFA-v5.ccb_discharge_dose",
      "path" : "NHFA-v5.ccb_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Calcium channel blocker dose at discharge.",
      "short" : "ccb_discharge_dose"
    }, {
      "id" : "NHFA-v5.statin_discharge",
      "path" : "NHFA-v5.statin_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Statin prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "statin_discharge"
    }, {
      "id" : "NHFA-v5.statin_discharge_dose",
      "path" : "NHFA-v5.statin_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Statin dose at discharge.",
      "short" : "statin_discharge_dose"
    }, {
      "id" : "NHFA-v5.warfarin_discharge",
      "path" : "NHFA-v5.warfarin_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Warfarin prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "warfarin_discharge"
    }, {
      "id" : "NHFA-v5.inr_discharge",
      "path" : "NHFA-v5.inr_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "INR at discharge.",
      "short" : "inr_discharge"
    }, {
      "id" : "NHFA-v5.warfarin_discharge_dose",
      "path" : "NHFA-v5.warfarin_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Warfarin dose at discharge.",
      "short" : "warfarin_discharge_dose"
    }, {
      "id" : "NHFA-v5.other_oral_anticoagulant_discharge",
      "path" : "NHFA-v5.other_oral_anticoagulant_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Any oral anticoagulant, other than warfarin, prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "other_oral_anticoagulant_discharge"
    }, {
      "id" : "NHFA-v5.other_oral_anticoagulant_discharge_dose",
      "path" : "NHFA-v5.other_oral_anticoagulant_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Oral anticoagulant dose at discharge.",
      "short" : "other_oral_anticoagulant_discharge_dose"
    }, {
      "id" : "NHFA-v5.amiodarone_discharge",
      "path" : "NHFA-v5.amiodarone_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Amiodarone prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "amiodarone_discharge"
    }, {
      "id" : "NHFA-v5.amiodarone_discharge_dose",
      "path" : "NHFA-v5.amiodarone_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Amiodarone dose at discharge.",
      "short" : "amiodarone_discharge_dose"
    }, {
      "id" : "NHFA-v5.allopurinol_discharge",
      "path" : "NHFA-v5.allopurinol_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Allopurinol prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "allopurinol_discharge"
    }, {
      "id" : "NHFA-v5.allopurinol_discharge_dose",
      "path" : "NHFA-v5.allopurinol_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Allopurinol dose at discharge.",
      "short" : "allopurinol_discharge_dose"
    }, {
      "id" : "NHFA-v5.nsaid_discharge",
      "path" : "NHFA-v5.nsaid_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Non-steroidal anti-inflammatory drug prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "nsaid_discharge"
    }, {
      "id" : "NHFA-v5.oral_nitrates_discharge",
      "path" : "NHFA-v5.oral_nitrates_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Oral nitrates prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "oral_nitrates_discharge"
    }, {
      "id" : "NHFA-v5.oral_nitrates_discharge_dose",
      "path" : "NHFA-v5.oral_nitrates_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "integer",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/integer" ]
      } ],
      "definition" : "Oral nitrates dose at discharge.",
      "short" : "oral_nitrates_discharge_dose"
    }, {
      "id" : "NHFA-v5.diabetes_therapy_discharge",
      "path" : "NHFA-v5.diabetes_therapy_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "'The diabetes therapy that the patient was prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking a diabetes therapy when admitted, and it was stopped during the admission. Diabetes therapy 0. No to be selected on its own (no other options can be selected if 0. No is chosen). Please complete the SGLT2 inhibitors field if this option is selected.",
      "short" : "diabetes_therapy_discharge"
    }, {
      "id" : "NHFA-v5.ivabradine_discharge",
      "path" : "NHFA-v5.ivabradine_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Ivabradine prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "ivabradine_discharge"
    }, {
      "id" : "NHFA-v5.ivabradine_discharge_dose",
      "path" : "NHFA-v5.ivabradine_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Ivabradine dose at discharge.",
      "short" : "ivabradine_discharge_dose"
    }, {
      "id" : "NHFA-v5.hydralazine_discharge",
      "path" : "NHFA-v5.hydralazine_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Hydralazine prescribed at point of discharge. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "hydralazine_discharge"
    }, {
      "id" : "NHFA-v5.hydralazine_discharge_dose",
      "path" : "NHFA-v5.hydralazine_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "Hydralazine dose at discharge.",
      "short" : "hydralazine_discharge_dose"
    }, {
      "id" : "NHFA-v5.arni_discharge",
      "path" : "NHFA-v5.arni_discharge",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The ARNI that the patient was prescribed at point of discharge. Contraindicated should be selected if an ARNI is not tolerated by the patient. Not applicable should be selected if this therapy is not clinically indicated for the type of heart failure that the patient has. Drug therapy stopped should be selected if the patient was taking this therapy when admitted, and it was stopped during the admission.",
      "short" : "arni_discharge"
    }, {
      "id" : "NHFA-v5.arni_discharge_dose",
      "path" : "NHFA-v5.arni_discharge_dose",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "decimal",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/decimal" ]
      } ],
      "definition" : "ARNI dose at discharge, 50mg to 400mg  - do not include dose if ARNI is recorded as 'Other'",
      "short" : "arni_discharge_dose"
    }, {
      "id" : "NHFA-v5.arni_contraindication_discharge",
      "path" : "NHFA-v5.arni_contraindication_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "1=The cause of cough severe should be investigated and ARNI stopped only when cough is very troublesome, persistent and not due to other causes.\n2=A low pressure that is asymptomatic and is not comprising renal function or other end-organs is not a reason to stop an ARNI.\n3=Serum creatinine exceeding 250umol/L.\n4=Other intolerance to ARNI \n6=Serum potassium >5.5mmol/L.\"\n7. Angioedema\"",
      "short" : "arni_contraindication_discharge"
    }, {
      "id" : "NHFA-v5.sglt2_inhibitors_discharge",
      "path" : "NHFA-v5.sglt2_inhibitors_discharge",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Please report SGLT2 inhibitors prescribed for any reason (heart failure, diabetes or both) here. ",
      "short" : "sglt2_inhibitors_discharge"
    }, {
      "id" : "NHFA-v5.confirmed_diagnosis_of_heart_failure",
      "path" : "NHFA-v5.confirmed_diagnosis_of_heart_failure",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "0=The diagnosis of heart failure has been excluded by imaging or by a cardiologist during this admission.\n1=The diagnosis of heart failure has been confirmed by imaging or BNP testing either during this admission or at a previous time. In some cases a clinician may justifiably diagnose heart failure in the absence of echocardiography.\n9=No information about imaging or BNP is available to support a diagnosis of heart failure.",
      "short" : "confirmed_diagnosis_of_heart_failure"
    }, {
      "id" : "NHFA-v5.heart_failure_diagnosis",
      "path" : "NHFA-v5.heart_failure_diagnosis",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "short" : "heart_failure_diagnosis"
    }, {
      "id" : "NHFA-v5.referral_to_the_hospital_heart_failure",
      "path" : "NHFA-v5.referral_to_the_hospital_heart_failure",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred for follow-up with a heart failure specialist nurse - this could be at a hospital. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to a heart failure nurse service following discharge.",
      "short" : "referral_to_the_hospital_heart_failure"
    }, {
      "id" : "NHFA-v5.referral_to_cardiac_rehabilitation",
      "path" : "NHFA-v5.referral_to_cardiac_rehabilitation",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to a cardiac rehabilitation programme. Cardiac rehabilitation usually involves an exercise-based programme that includes educational and psychological support, but can occur without an exercise component if the patient cannot tolerate exercise. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to a cardiac rehabilitation programme following discharge.",
      "short" : "referral_to_cardiac_rehabilitation"
    }, {
      "id" : "NHFA-v5.referral_for_cardiothoracic_surgery_made",
      "path" : "NHFA-v5.referral_for_cardiothoracic_surgery_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred for cardiothoracic surgery at discharge. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred for cardiothoracic surgery following discharge.",
      "short" : "referral_for_cardiothoracic_surgery_made"
    }, {
      "id" : "NHFA-v5.referral_for_transplant_made",
      "path" : "NHFA-v5.referral_for_transplant_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred for a heart transplant at discharge. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred for a heart transplant following discharge.",
      "short" : "referral_for_transplant_made"
    }, {
      "id" : "NHFA-v5.referral_to_palliative_care_services_made",
      "path" : "NHFA-v5.referral_to_palliative_care_services_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to specialist palliative care services at discharge. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to specialist palliative care services following discharge.",
      "short" : "referral_to_palliative_care_services_made"
    }, {
      "id" : "NHFA-v5.referral_to_cardiology_follow_up_made",
      "path" : "NHFA-v5.referral_to_cardiology_follow_up_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to follow-up with or involving a cardiologist. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to cardiology follow-up following discharge.",
      "short" : "referral_to_cardiology_follow_up_made"
    }, {
      "id" : "NHFA-v5.referral_to_the_community_heart_failure_nurse_follow_up_made",
      "path" : "NHFA-v5.referral_to_the_community_heart_failure_nurse_follow_up_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred for follow-up with a community heart failure specialist nurse - this could be at a hospital. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to a community heart failure nurse service following discharge.",
      "short" : "referral_to_the_community_heart_failure_nurse_follow_up_made"
    }, {
      "id" : "NHFA-v5.referral_to_hf_cardiologist_follow_up_made",
      "path" : "NHFA-v5.referral_to_hf_cardiologist_follow_up_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to follow-up with or involving a heart failure cardiologist. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to a heart failure cardiologist follow-up following discharge.",
      "short" : "referral_to_hf_cardiologist_follow_up_made"
    }, {
      "id" : "NHFA-v5.date_of_discharge_or_death",
      "path" : "NHFA-v5.date_of_discharge_or_death",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "date",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/date" ]
      } ],
      "definition" : "The date on which the patient was discharged from hospital or died. ",
      "short" : "date_of_discharge_or_death"
    }, {
      "id" : "NHFA-v5.appointment_with_the_specialist_multidisciplinary_hf_team_made",
      "path" : "NHFA-v5.appointment_with_the_specialist_multidisciplinary_hf_team_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Review appointment with a member of the heart failure multi-disciplinary team, following discharge. This could be a consultant cardiologist, other consultant with interest in heart failure, heart failure nurse specialist, primary care physician with specific remit for heart failure patients or a heart failure specialist pharmacist. This should not be speculative, and yes should only be selected if the date of the appointment is decided. ",
      "short" : "appointment_with_the_specialist_multidisciplinary_hf_team_made"
    }, {
      "id" : "NHFA-v5.date_of_review_appointment",
      "path" : "NHFA-v5.date_of_review_appointment",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "date",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/date" ]
      } ],
      "definition" : "If a review appointment has been arranged, insert the date of the review appointment. NICE recommends that the appointment should be within 2 weeks of discharge. If multiple follow-up appointments, e.g. with HFSN and cardiologist, record the date of the first one here. If date of review appointment known, please fill it in. If date of review appointment is unknown, please use the patient's date of admission (field 2.00). ",
      "short" : "date_of_review_appointment"
    }, {
      "id" : "NHFA-v5.patient_stable_on_oral_therapy_after_discharge_planning",
      "path" : "NHFA-v5.patient_stable_on_oral_therapy_after_discharge_planning",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Stability on oral therapy prior to discharge. Stability means that a patient's prescription levels have not been changed, and that their weight and renal function are stable, for 48 hours prior to discharge. ",
      "short" : "patient_stable_on_oral_therapy_after_discharge_planning"
    }, {
      "id" : "NHFA-v5.death_in_hospital",
      "path" : "NHFA-v5.death_in_hospital",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Patient deceased before being discharged from hospital. If yes, date of discharge should be date of death.",
      "short" : "death_in_hospital"
    }, {
      "id" : "NHFA-v5.referral_to_hf_specialist_pharmacist_follow_up_made",
      "path" : "NHFA-v5.referral_to_hf_specialist_pharmacist_follow_up_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to follow-up with or involving a HF specialist pharmacist. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to a HF specialist pharmacist follow-up following discharge.",
      "short" : "referral_to_hf_specialist_pharmacist_follow_up_made"
    }, {
      "id" : "NHFA-v5.is_a_heart_failure_pre_discharge_management_plan_in_place",
      "path" : "NHFA-v5.is_a_heart_failure_pre_discharge_management_plan_in_place",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The personalised pre-discharge management plan that is drawn up for the patient prior to discharge. Ideally this should be discussed with the patient and their carers, and should include advice about lifestyle, medicines, weight management, monitoring signs and symptoms, disease prognosis and palliative care if appropriate. A discharge plan should be communicated to the primary care team, including discussion of up-titration and continuation of medicines and ongoing care outside of hospital. The discharge plan should take into account patient and carer wishes, and the level of care and support that can be provided in the community.",
      "short" : "is_a_heart_failure_pre_discharge_management_plan_in_place"
    }, {
      "id" : "NHFA-v5.heart_failure_management_plan_been_discussed_with_the_patient",
      "path" : "NHFA-v5.heart_failure_management_plan_been_discussed_with_the_patient",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The personalised pre-discharge management plan that is drawn up for the patient prior to discharge. Ideally this should be discussed with the patient and their carers, and should include advice about lifestyle, medicines, weight management, monitoring signs and symptoms, disease prognosis and palliative care if appropriate. A discharge plan should be communicated to the primary care team, including discussion of up-titration and continuation of medicines and ongoing care outside of hospital. The discharge plan should take into account patient and carer wishes, and the level of care and support that can be provided in the community.",
      "short" : "heart_failure_management_plan_been_discussed_with_the_patient"
    }, {
      "id" : "NHFA-v5.management_plan_been_communicated_to_the_primary_care_team",
      "path" : "NHFA-v5.management_plan_been_communicated_to_the_primary_care_team",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "The personalised pre-discharge management plan that is drawn up for the patient prior to discharge. Ideally this should be discussed with the patient and their carers, and should include advice about lifestyle, medicines, weight management, monitoring signs and symptoms, disease prognosis and palliative care if appropriate. A discharge plan should be communicated to the primary care team, including discussion of up-titration and continuation of medicines and ongoing care outside of hospital. The discharge plan should take into account patient and carer wishes, and the level of care and support that can be provided in the community.",
      "short" : "management_plan_been_communicated_to_the_primary_care_team"
    }, {
      "id" : "NHFA-v5.referral_to_gp_with_special_interest_in_hf_made",
      "path" : "NHFA-v5.referral_to_gp_with_special_interest_in_hf_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to follow-up with or involving a GP with special interest in HF. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to GP with special interest in HF follow-up following discharge.",
      "short" : "referral_to_gp_with_special_interest_in_hf_made"
    }, {
      "id" : "NHFA-v5.is_the_first_hf_follow_up_appointment_within_2_weeks",
      "path" : "NHFA-v5.is_the_first_hf_follow_up_appointment_within_2_weeks",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "If a review appointment has been arranged, insert the date of the appointment. NICE recommends that the appointment should be within 2 weeks of discharge. ",
      "short" : "is_the_first_hf_follow_up_appointment_within_2_weeks"
    }, {
      "id" : "NHFA-v5.patient_transferred_to_another_hospital",
      "path" : "NHFA-v5.patient_transferred_to_another_hospital",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "If patient transferred to another hospital select, please select yes. ",
      "short" : "patient_transferred_to_another_hospital"
    }, {
      "id" : "NHFA-v5.referral_to_geriatrician_with_interest_in_hf_made",
      "path" : "NHFA-v5.referral_to_geriatrician_with_interest_in_hf_made",
      "min" : 1,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Referred to follow-up with or involving a geriatrician with interest in HF. This should record referral at the point of discharge, so 'Yes' should be selected if the patient will be referred to geriatrician with interest in HF follow-up following discharge.",
      "short" : "referral_to_geriatrician_with_interest_in_hf_made"
    }, {
      "id" : "NHFA-v5.sglt2_inhibitors_admission",
      "path" : "NHFA-v5.sglt2_inhibitors_admission",
      "min" : 0,
      "max" : "1",
      "type" : [ {
        "code" : "code",
        "profile" : [ "http://hl7.org/fhir/StructureDefinition/code" ]
      } ],
      "definition" : "Please report SGLT2 inhibitors prescribed for any reason (heart failure, diabetes or both) here.",
      "short" : "sglt2_inhibitors_admission"
    } ]
  }
}